Growth potential of female prolactinomas

Surgical Neurology

Volumn 55, Issue 4, 2001, Pages 213-217

  Nishioka, Hiroshi ^a   Ito, Hiroshi ^a   Haraoka, Jo ^a   Hirano, Asao ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Growth potential; Pituitary adenomas; Prolactin; Prolactinomas

Indexed keywords

ESTROGEN; KI 67 ANTIGEN; PROLACTIN;

ADENOMA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENDOCRINE FUNCTION TEST; ESTROGEN DEFICIENCY; FEMALE; FERTILITY; GROWTH; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; DYSMENORRHEA; ESTROGENS; FEMALE; GROWTH; HUMANS; HYPERPROLACTINEMIA; HYPOPITUITARISM; KI-67 ANTIGEN; MIDDLE AGED; PITUITARY NEOPLASMS; PROGNOSIS; PROLACTIN; PROLACTINOMA;

EID: 0035012315     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(01)00407-4     Document Type: Article

References (15)

1. Abe T., Sanno N., Osamura Y.R., Matsumoto K. Proliferative potential in pituitary adenomas measurement by monoclonal antibody MIB-1 . Acta Neurochir (Wien). 139:1997;613-618.
2. Biller B.M.K., Baum H.B.A., Rosenthal D.I., Saxe V.C., Charpie P.M., Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 75:1992;692-697.
3. Calle-Rodrigue R.D.P., Giannini C., Scheithauer B.W., Lloyd R.V., Wollan P.C., Kovacs K.T., Stefaneanu L., Ebright A.B., Abboud C.F., Davis D.H. Prolactinomas in male and female patients a comparative clinicopathological study . Mayo Clin Proc. 73:1998;1046-1105.
4. Jeffcoate W.J., Pound N., Sturrock N.D.C., Lambourne J. Long-term follow-up of patients with hyperprolactinemia. Clin Endocrinol. 45:1996;299-303.
5. Katznelson L., Klibanski A. Prolactinomas. Arnold A. Endocrine Neoplasms. 1997;41-55 Kluver Academic Publ, Boston.
6. Klibanski A., Neer R.M., Beitins I.Z., Ridgway E.C., Zervas N.T., McArthur J.W. Decreased bone density in hyperprolactinemic women. N Engl J Med. 303:1980;1511-1514.
7. Koppelman M.C.S., Jaffe M.J., Rieth K.G., Caruso R.C., Loriaux D.L. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. Ann Intern Med. 100:1984;115-121.
8. March C.M., Kletzky O., Davajan V., Teal J., Weiss M., Apuzzo M.L.J., Marrs R.P., Mishell D.R. Jr. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol. 139:1981;835-844.
9. McComb D.J., Ryan N., Horvath E., Kovacs K. Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med. 107:1983;488-491.
10. Molitch M.E. Diagnosis and treatment of prolactinomas. Adv Intern Med. 44:1999;117-153.
11. Molitch M.E. Prolactinomas. Melmed S. The Pituitary. 1995;443-477 Blackwell Science, Cambridge.
12. Schlechte J., Dolan K., Sherman B., Chapler F., Luciano A. The natural history of untreated hyperprolactinemia a prospective analysis . J Clin Endocrinol Metab. 68:1989;412-418.
13. Sisam D.A., Sheehan J.P., Sheeler L.R. The natural history of untreated microprolactinomas. Fertil Steril. 48:1987;67-71.
14. Thapar K., Kovacs K., Scheithauer B.W., Stefaneanu L., Horvath E., Pernicone P.J., Murray D., Laws E.R. Jr. Proliferative activity and invasiveness among pituitary adenomas and carcinomas an analysis using the MIB-1 antibody . Neurosurgery. 38:1996;99-107.
15. Weiss M.H., Teal J., Gott P., Wycoff R., Yadley R., Apuzzo M.L.J., Giannotta S.L., Kletzky O., March C. Natural history of microprolactinomas six-year follow-up . Neurosurgery. 12:1983;180-183.